Cleared Traditional

K252893 - ExaStim® Stimulation System (EXA-001) (FDA 510(k) Clearance)

Also includes:
ExaStim® Stimulation System (EXA-011) ReCure® Electrode Pad (PAD-003) ReCure® Electrode Pad (PAD-013)
Mar 2026
Decision
197d
Days
Class 2
Risk

K252893 is an FDA 510(k) clearance for the ExaStim® Stimulation System (EXA-001). This device is classified as a Transcutaneous Electrical Spine Stimulator To Improve Skeletal Muscle Strength And Sensation (Class II - Special Controls, product code SDO).

Submitted by Aneuvo (Los Angeles, US). The FDA issued a Cleared decision on March 27, 2026, 197 days after receiving the submission on September 11, 2025.

This device falls under the Physical Medicine FDA review panel. Regulated under 21 CFR 890.5851. A Transcutaneous Electrical Spine Stimulator To Improve Skeletal Muscle Strength And Sensation Is A Device That Can Be Programmed To Apply An Electrical Current Via Electrodes On A Patient's Skin Over The Spine To Improve Muscle Strength And Sensation After Neurological Deficit..

Submission Details

510(k) Number K252893 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 11, 2025
Decision Date March 27, 2026
Days to Decision 197 days
Submission Type Traditional
Review Panel Physical Medicine (PM)
Summary Summary PDF

Device Classification

Product Code SDO - Transcutaneous Electrical Spine Stimulator To Improve Skeletal Muscle Strength And Sensation
Device Class Class II - Special Controls
CFR Regulation 21 CFR 890.5851
Definition A Transcutaneous Electrical Spine Stimulator To Improve Skeletal Muscle Strength And Sensation Is A Device That Can Be Programmed To Apply An Electrical Current Via Electrodes On A Patient's Skin Over The Spine To Improve Muscle Strength And Sensation After Neurological Deficit.